Back
GE Vernova, Inc. Vs. Sarepta Therapeutics, Inc. Sector Stock Comparison
Buy
78
GEV
GE Vernova, Inc.
Last Price:
$663.43
Seasonality Move:
-7.89%
Sell
44
SRPT
Sarepta Therapeutics, Inc.
Last Price:
$22.10
Seasonality Move:
6.08%
Buy
78
GE Vernova, Inc. (GEV)
is a Buy
Is GE Vernova, Inc. a Buy, Sell or Hold?
-
The current GE Vernova, Inc. [GEV] share price is $667.32. The Score for GEV is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
GEV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Sarepta Therapeutics, Inc. (SRPT)
is a Sell
Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Sarepta Therapeutics, Inc. [SRPT] share price is $22.32. The Score for SRPT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GEV Stock Price Chart
What is GE Vernova, Inc.'s stock price today?
-
The GE Vernova, Inc. share price today is $667.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GEV is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics, Inc.'s stock price today?
-
The Sarepta Therapeutics, Inc. share price today is $22.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
GEV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 18.71 | Buy |
| Relative Strength Index (14 RSI): | 56.8 | Buy |
| Chaikin Money Flow: | 209340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (583.26 - 673.44) | Buy |
| Bollinger Bands (100): | (577.66 - 645.62) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.69 | Buy |
| Relative Strength Index (14 RSI): | 57.4 | Buy |
| Chaikin Money Flow: | 705480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 22.53) | Buy |
| Bollinger Bands (100): | (17.77 - 22.29) | Buy |
GEV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 658.76 | Buy |
| 20-day SMA: | 642.33 | Buy |
| 50-day SMA: | 603.36 | Buy |
| 200-day SMA: | 527.04 | Buy |
| 8-day EMA: | 658.99 | Buy |
| 20-day EMA: | 642.73 | Buy |
| 50-day EMA: | 619.25 | Buy |
| 200-day EMA: | 532.79 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.49 | Buy |
| 20-day SMA: | 21.54 | Buy |
| 50-day SMA: | 20.78 | Buy |
| 200-day SMA: | 30.87 | Sell |
| 8-day EMA: | 16.81 | Buy |
| 20-day EMA: | 9.68 | Buy |
| 50-day EMA: | 4.56 | Buy |
| 200-day EMA: | 1.24 | Buy |
GE Vernova, Inc. Earnings Growth & GEV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.53 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and an increase next year of $5.92 per share.
Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.05 per share, and an increase next year of $4.83 per share.
GE Vernova, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||